Dongwha Pharm.Co.Ltd Balance Sheet Health
Financial Health criteria checks 4/6
Dongwha Pharm.Co.Ltd has a total shareholder equity of ₩405.9B and total debt of ₩57.8B, which brings its debt-to-equity ratio to 14.2%. Its total assets and total liabilities are ₩587.1B and ₩181.2B respectively. Dongwha Pharm.Co.Ltd's EBIT is ₩8.9B making its interest coverage ratio -5.7. It has cash and short-term investments of ₩40.1B.
Key information
14.2%
Debt to equity ratio
₩57.82b
Debt
| Interest coverage ratio | -5.7x |
| Cash | ₩40.09b |
| Equity | ₩405.92b |
| Total liabilities | ₩181.18b |
| Total assets | ₩587.11b |
Recent financial health updates
These 4 Measures Indicate That Dongwha Pharm.Co.Ltd (KRX:000020) Is Using Debt Safely
Mar 11
Is Dongwha Pharm.Co.Ltd (KRX:000020) Using Too Much Debt?
Dec 04Recent updates
Dongwha Pharm.Co.Ltd's (KRX:000020) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Nov 20Dongwha Pharm.Co.Ltd's (KRX:000020) Promising Earnings May Rest On Soft Foundations
Mar 26Is Dongwha Pharm.Co.,Ltd (KRX:000020) A Smart Pick For Income Investors?
Apr 28These 4 Measures Indicate That Dongwha Pharm.Co.Ltd (KRX:000020) Is Using Debt Safely
Mar 11Dongwha Pharm.Co.,Ltd (KRX:000020) Has A ROE Of 8.6%
Feb 22Is Dongwha Pharm.Co.Ltd's (KRX:000020) Share Price Gain Of 102% Well Earned?
Feb 07Should Dongwha Pharm.Co.,Ltd (KRX:000020) Be Part Of Your Dividend Portfolio?
Jan 23Is Dongwha Pharm.Co.,Ltd (KRX:000020) Popular Amongst Insiders?
Jan 08
Dongwha Pharm.Co.,Ltd (KRX:000020) Pays A ₩120 Dividend In Just Four Days
Dec 24We're Not Counting On Dongwha Pharm.Co.Ltd (KRX:000020) To Sustain Its Statutory Profitability
Dec 19Is Dongwha Pharm.Co.Ltd (KRX:000020) Using Too Much Debt?
Dec 04Can Dongwha Pharm.Co.,Ltd (KRX:000020) Improve Its Returns?
Nov 19Financial Position Analysis
Short Term Liabilities: A000020's short term assets (₩218.2B) exceed its short term liabilities (₩108.2B).
Long Term Liabilities: A000020's short term assets (₩218.2B) exceed its long term liabilities (₩73.0B).
Debt to Equity History and Analysis
Debt Level: A000020's net debt to equity ratio (4.4%) is considered satisfactory.
Reducing Debt: A000020's debt to equity ratio has increased from 0% to 14.2% over the past 5 years.
Debt Coverage: A000020's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: A000020 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 17:20 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dongwha Pharm.Co.,Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dodo Cheng | HSBC |